Leonard Resignation Leaves AAM Looking For New Leadership
Gaugh Steps In As Interim CEO Of US Generics And Biosimilars Association
Executive Summary
Dan Leonard has announced his resignation as president and CEO of the US Association for Accessible Medicines. He will be replaced on an interim basis by the group’s vice president for sciences and regulatory affairs, David Gaugh.
You may also be interested in...
PBMs’ ‘Perverse Incentives’ Still Limiting Generics Access, AAM Report Reiterates
Generic medicines continue to be intentionally left off formulary tiers in favor of more expensive brand medications, according to a new report from the US Association for Accessible Medicines.
A Bad Fit: Dan Leonard’s Leadership Style Did Not Translate At AAM
Former employees at the Association for Accessible Medicines detail problems that emerged during Leonard’s tenure, but also say the board of directors must improve its management of the trade organization.
AAM Welcomes CMS Tiers Rule For Generics
A proposed rule set out by the US Centers for Medicare & Medicaid Services directing that generics should be covered on generic tiers has been commended by local off-patent industry group the US Association for Accessible Medicines.